Dangos, Brielle Ambere .

HRN: 25-79-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMPICILLIN 1GM (VIAL)
10/17/2024
10/24/2024
IV
320mg
Q6hrs
Acute Bacterial Infection
Waiting Final Action 
10/17/2024
AMPICILLIN 1GM (VIAL)
10/17/2024
10/24/2024
IV
430
Q6h
Acute Bacterial Infection
Waiting Final Action 
10/19/2024
MUPIROCIN 2%, 15G (TUBE)
10/19/2024
10/25/2024
TOPICAL
Pea Sized
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: